Response to Crizotinib in ROS1 Fusion-Positive Intrahepatic Cholangiocarcinoma.

ABSTRACT:

SUBMITTER: Jakubowski CD 

PROVIDER: S-EPMC9797238 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature